Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey
Tatjana Potpara(University of Belgrade), Nikolaos Dagres(Leipzig University), Pantelis Sarafidis(Ippokrateio General Hospital of Thessaloniki), Gregory Y.H. Lip(Medical University of Białystok), Charles J. Ferro(Queen Elizabeth Hospital Birmingham), Radosław Lenarczyk(Silesian Center for Heart Disease), Alberto Ortíz(Universidad Pontificia de Salamanca), Robert Ekart(University of Maribor), George Andrei Dan(Carol Davila University of Medicine and Pharmacy), Francesca Mallamaci(Società Italiana di Nefrologia)
Cited by 53
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k